Personalised Health Care

Stefania Boccia, PhD, DSc, MS , is Full professor of Hygiene, Preventive Medicine and Public Health at Università Cattolica del Sacro Cuore (UCSC) in Rome, Italy. She is the Director of the Section of Hygiene of the Department of Health Science and Public Health of UCSC and President of the Public Health Epidemiology Section of European Public Health Association (EUPHA). A Biologist by training and Specialist in Clinical Pathology, she obtained a Master of Science in Epidemiology and Biostatistics and a Doctor of Science and PhD in Genetic Epidemiology at the Erasmus MC in Rotterdam, the Netherlands. From 2016 to 2018 she was Adjunct Professor at Mount Sinai Medical School in New York, NY, USA. In 2018 she founded the spin-off "Vihtali srl" (Value In Health Technology and Academy for Leadership & Innovation) at UCSC. She currently coordinates the project titled "European network staff eXchange for integrAting precision health in the health Care sysTems" (ExACT) funded by the European Commission (EC) within the H2020 Marie-Slodowska Curie projects (MSCA-RISE). She is currently partner of several EU-funded projects; among them is "Integrating China in the International Consortium for Personalised Medicine" (IC2PerMed, CSA) as a member of the Coordinating group. She is author and co-author of 216 scientific publications; her h-index (Scopus) is 37 and citation count is 5350. Róza Ádány, MD, PhD, DSc , is a medical doctor with specialization in the field of preventive medicine and public health. She is Professor of public health at the University of Debrecen, Hungary; founding Dean of the Faculty of Public Health; leader of the Public Health Research Group funded by the Hungarian Academy of Sciences; head of the WHO Collaborating Centre on Vulnerability and Health; and President of the Public Health Genomics Section of the European Public Health Association. She also acts as president of the Hungarian Association of Public Health Training and Research Institutes, chief editor of the journal 'Népegészségügy' (Public Health), editorial member of the European Journal of Public Health, associate editor of the Frontiers in Public Health journal, and Vice-Chair of the European Advisory Committee on Health Research for WHO European Region. She was chairperson of the Association of Schools of Public Health in the European Region (ASPHER) between 2001-2003. She contributed as expert adviser to the development of the revised version of the Health for All and the draft of the Health 2020 strategies of the WHO Europe. She is author and co-author of 237 scientific publications; her h-index (Scopus) is 33 and citation count (Scopus) is 4634. She received several prestigious Hungarian and international awards in acknowledgement of her work. Paolo Villari, MD, MPH , is Full professor of Hygiene and, since 2015, is Director of the Department of Public Health and Infectious Diseases at Sapienza University of Rome, Italy, where he also is Member of the Academic Senate. A graduate in Medicine and Surgery and Specialist in Hygiene and Preventive Medicine, he obtained the Master's Degree in Public Health at Harvard University. As former President of the Epidemiology Section of the European Public Health Association (EUPHA) in the years 2004-2006 and national delegate for Italy to the Federation of European Academies of Medicine (FEAM) from 2007 to 2013, he was Deputy Secretary General of the FEAM from 2010 to 2013. A member of the Scientific Committee at the Ministry of Health, Directorate General of Health Planning, from 2011 to 2013, he is currently Chairman of the National Committee for the Verification of measles and rubella elimination. He is responsible for international and national research projects, funded by the University, Ministry of Health, Ministry of University, EU in the fields of epidemiology of infectious diseases, health management and health ser

Introduction (Boccia).- 1. Chapter 1: Identification of biomarkers for the prevention of chronic disease (Editors: Adany, Boccia).- 2. Chapter 2: Evaluation of predictive genomic applications (Editor: Villari). -3. Chapter 3: Ethico-legal and policy issues surrounding personalised medicine (Editor: Sandor).-  olicy issue, with a focus on citizens and DTC) 3.4 Sandor (Legal issue).- 4. Chapter 4: Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis (Editor: Cornel).- 5. Chapter 5: Identification of organizational models for the provision of predictive genomic applications (Editor: De Vito).